This ‘Molecular Shield’ Might Stop Pollen Before It Wrecks Your Nose

Every year, Pollen chapters grow longer and more intenseI have into a great misery of suffering from Pollen Allergies – myself. What can do with antihistamines or hot towels, and a protective sized mask, firmly shut down glass windows, endless sneezing, flowing noses and itching offers any protection.

But before you obey your sensitive nasal crossings by spraying the fault spray, do you block the raid of these frustrating allergens before?

It was a “simple but strong idea” that inspired Kaissar TabynovThe efforts to create a “molecular shield” with separatrasi have made an effort to cut the moment they approached our airline. For practice, they targeted Mugwort Polen The most common cause of pollen allergies In Central Asia and Europe. Tabinov and his colleagues informed this technology today on this instance about the first evidence of this equipment in a paper published today Borders in immunology.

“Allergies are often evaluated as inconvenient, but small conditions, but can seriously reduce the quality of life for millions of people,” Sibrinov, Director of the Agrarian Research University of Kazakhstan, Kazakhstan University of Agrarian Research of Kazakhstan. “We believe that this may be the beginning of a new class of anti-allergy interventions in a way that it cannot protect people during the allergies.”

How “Shield” works. Researchers first develop a lab designed to close a monoclonal antibody, or a certain molecule. In this case, a great allergies found in Mugwort pollen were directed to protein. These antibodies are applied to the nose, trigger allergic answers when allergic is related to allergies, captures our allergies effectively.

The immune system is a complex network of cells and hormones, so it regulates the treatment, it has proved that this is a natural problem. At the same time, Mugwort Pollen was in fact a combination of particles that caused a large number of allergies (partly so-intolerable reasons), the Muginov team, which means, the most clinically relevant parts of the Allergen complex.

After several amendments, the team succeeded in the treatment of asthma’s symptoms and asthma symptoms in mice, and this did not harm the natural antibodies of animals. Although the term of treatment is shorter than SMainov, he said that he and his team had already prepared a strategy to make treatment potential for longer.

“What is interesting for our approach, not only for chronic therapy, not for prevention, targeted biologists can be used, and allergens are delivered in the place where allergens are reported,” he said. “Our approach is non-invasive, improvisable and fast [and] Reduces allergen loads in the immune system and can help prevent the progress of allergic rhinitis to more severe conditions like a bronchial asthma. “

As soon as the Sollen Allergy patients are known, allergic reactions tend to build a chain reaction along the body. The idea of ​​blocking before the allergens reached the nose, for many patients, especially for those who prevent the adoption of standard antihistamine pills, it would be a great relief. Alternatively alternative to immunotherapy sessions that save once a time is an alternative to any effect.

So this is something we will soon get in a local pharmacy? Dependent. Tabinov’s most optimistic estimate is that the first person’s research can occur in two to three years. The treatment needs additional adjustments to expand the protective effects on human noses. However, lifetime sounds like a promising start for Pollen patients.